EUCTR2008-002454-37-IT进行中（未招募）不适用
intrarterial chemotherapy with liposomial doxorubicin for recurrent glioblastoma affected patients. Phase II study. - intrarterial cht with myocet for recurrent glioblastoma
ISTITUTO NAZIONALE PER LA CURA TUMORI0 个研究点开始时间: 2008年11月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age 18-75, life expectance almost 3 months, grade 3 or 4 histological diagnosis of recurrent glioblastoma after surgical and/or radio/chemotherapy approach, untreated pts with anthracycline, Karnofsky >70
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous anthracycline based therapy, heart failure, RT and CHT finishes 3 weeks before study start
研究者
相似试验
进行中（未招募）
不适用
iposomial doxorubicin Investigational chemotherapy - Tissue doppler imaging -EvaluatioFirst line treatment on female breast cancerMedDRA version: 6.1Level: PTClassification code 10006199EUCTR2005-003092-20-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中（未招募）
不适用
Chimiothérapie intra-arterielle lipiodolée (CIAL) versus chimiothérapie systémique par gemcitabine et oxaliplatine (GEMOX) versus surveillance simple après résection ou destruction des carcinomes hépatocellulaires sur cirrhose - GEMOXIAcarcinome hépatocellulaire sur cirrhoseMedDRA version: 8.1Level: PTClassification code 10051571Term: carcinome hépatocellulaire sur cirrhoseEUCTR2006-005456-32-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Unknown
2 期
Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00742404Oncotherapeutics35
进行中（未招募）
不适用
'Pilot trial of Pegilated Liposomal Doxorrubicin (Caelyx) in combination with Docetaxel (Taxotere) in advanced breast cancer patients'Estudio Piloto de Doxorrubicina Liposomal Pegilada (Caelyx) en combinación con Docetaxel (Taxotere) en pacientes con cáncer de mama avanzadoAdvanced Breast CancerEUCTR2005-001499-10-ESDr. José Ramón Mel Lorenzo
招募中
2 期
A Phase II Trial of Liposomal Doxorubicin (PLD, DOXILTM) as 3rd Line Treatment in Relapsed, Plutinum - resistant Ovarian CancerOvarian CancerJPRN-UMIN000002814Osaka University Faculty of Medicine Department of obstetrics and gynecology43